EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy

Diane Evrard, Aurélie Beaufrère, Clément Dumont, Séréna Louërat, Adrien Chaud, Alice Guyard, Samira Laouirem, Miguel Albuquerque, Annemilaï Tijeras-Raballand, Anne Couvelard, Valérie Paradis, Caroline Halimi und 3 weitere

Cancer Immunology, Immunotherapy · 2026

DOI: 10.1007/s00262-025-04282-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Diane Evrard und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Bichat Hospital, AP-HP. Nord-Université Paris Cité, 46 Rue Henri Huchard, 75018, Paris, Fran…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Head and Neck Neoplasms, Immunotherapy, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Nelia et Amadeo Barletta, Fondation de l’Avenir.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) and other PD-L1-expressing immune cells play a key role in head and neck squamous cell carcinoma (HNSCC). As PD-1 inhibitors have become standard therapy for recurrent/metastatic disease and are now used perioperatively in locally advanced resectable cases, understanding their impact on TAMs dynamics is critical. This study investigated the association between clinical features and TAMs prevalence in HNSCC, and their potential role in tumor progression and resistance to PD-1 blockade. Tumor samples from HNSCC patients were analyzed by simplex and multiplex immunohistochemistry, and fresh tumor slices were cultured ex vivo with PD-1 inhibitors. CD68 + and CD163 + macrophages and PD-L1 expression were quantified and correlated with clinical parameters. In a tissue microarray cohort of 96 patients, CD68 + and CD163 + macrophages were more abundant in oral and oropharyngeal tumors compared to laryngeal and hypopharyngeal carcinomas ( p = 0.001 and p = 0.06, respectively). In 10% of cases, TAMs formed a barrier between tumor nests and immune infiltrates. Among nine patients with matched pre- and post-immunotherapy samples, TAMs density significantly increased post-treatment ( p = 0.01 and p = 0.03), with CD163 + macrophages clustering at the tumor periphery in 78% of cases. Multiplex staining confirmed this spatial reorganization. Ex vivo exposure to PD-1 inhibitors reproduced the increase in TAMs. These results suggest that PD-1 blockade may foster M2-like macrophage accumulation, potentially contributing to immune evasion. This underscores the need for prospective studies and the development of macrophage-targeted strategies, particularly in the emerging context of perioperative immunotherapy in HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesHead and Neck NeoplasmsImmunotherapySquamous Cell Carcinoma of Head and NeckMacrophagesHumansFemaleMaleMiddle AgedAgedTumor MicroenvironmentAntigens, Differentiation, MyelomonocyticAntigens, CD

Stichwörter der Autor:innen

Head and neck squamous cell carcinomaImmunotherapy resistancePD-1 inhibitorsPerioperative immunotherapyTumor microenvironmentTumor-associated macrophages

Substanzen

Antigens, Differentiation, MyelomonocyticAntigens, CD

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Bichat Hospital, AP-HP. Nord-Université Paris Cité, 46 Rue Henri Huchard, 75018, Paris, France. diane.evrard@aphp.fr.
  • INSERM UMR 1149, Centre de Recherche Sur L'Inflammation, Paris, France. diane.evrard@aphp.fr.
  • INSERM UMR 1149, Centre de Recherche Sur L'Inflammation, Paris, France.
  • Department of Pathology, Beaujon Hospital, FHU MOSAIC, SiRIC InsiTu, AP-HP. Nord-Université Paris Cité, Clichy, France.
  • Medical Oncology Department, Saint-Louis Hospital, AP-HP. Nord-Université Paris Cité, Paris, France.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Bichat Hospital, AP-HP. Nord-Université Paris Cité, 46 Rue Henri Huchard, 75018, Paris, France.

Förderung

  • Fondation Nelia et Amadeo Barletta
  • Fondation de l’Avenir

Zitieren

APA

Evrard, D., Beaufrère, A., Dumont, C., Louërat, S., Chaud, A., Guyard, A., Laouirem, S., Albuquerque, M., Tijeras-Raballand, A., Couvelard, A., Paradis, V., Halimi, C., Raymond, É., Hourseau, M., & Faivre, S. (2026). Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04282-y

Vancouver

Evrard D, Beaufrère A, Dumont C, Louërat S, Chaud A, Guyard A, et al. Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-025-04282-y

BibTeX
@article{Evrard2026,
  author = {Evrard, Diane and Beaufrère, Aurélie and Dumont, Clément and Louërat, Séréna and Chaud, Adrien and Guyard, Alice and Laouirem, Samira and Albuquerque, Miguel and Tijeras-Raballand, Annemilaï and Couvelard, Anne and Paradis, Valérie and Halimi, Caroline and Raymond, Éric and Hourseau, Muriel and Faivre, Sandrine},
  title = {Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-025-04282-y}
}
Kostenlos starten →